Diagnosis of cystic fibrosis after newborn screening: The Australasian experience?twenty years and five million babies later: A consensus statement from the Australasian paediatric respiratory group
- 1 May 2005
- journal article
- review article
- Published by Wiley in Pediatric Pulmonology
- Vol. 39 (5), 440-446
- https://doi.org/10.1002/ppul.20191
Abstract
Newborn screening for cystic fibrosis has been used in Australia and New Zealand for over 20 years. In that time, considerable experience has been developed regarding the early diagnosis of cystic fibrosis after newborn screening. To date, there has not been a consensus on the process of screening and clinical evaluation leading to the diagnosis of cystic fibrosis in infants, many of whom are not symptomatic at time of notification of the screening result. The aim of this paper is to provide some consensus on the important issues of a cystic fibrosis diagnosis arising from newborn screening, based on the experience gained in Australia and New Zealand over the last 20 years.Keywords
This publication has 33 references indexed in Scilit:
- Pancreatic function and extended mutation analysis in ΔF508 heterozygous infants with an elevated immunoreactive trypsinogen but normal sweat electrolyte levelsThe Journal of Pediatrics, 2000
- A cystic fibrosis transmembrane conductance regulator splice variant with partial penetrance associated with variable cystic fibrosis presentations.American Journal of Respiratory and Critical Care Medicine, 1997
- Neonatal screening for cystic fibrosis: A comparison of two strategies for case detection in 1.2 million babiesThe Journal of Pediatrics, 1995
- Neonatal screening for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis: four years' experienceBMJ, 1994
- Variation of Sweat Sodium and Chloride with Age in Cystic Fibrosis and Normal Populations: Further Investigations in Equivocal CasesAnnals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1992
- Ion transport abnormalities in rectal suction biopsies from children with cystic fibrosisGastroenterology, 1991
- Neonatal screening strategy for cystic fibrosis using immunoreactive trypsinogen and direct gene analysis.BMJ, 1991
- Impaired chloride secretion, as well as bicarbonate secretion, underlies the fluid secretory defect in the cystic fibrosis pancreasGastroenterology, 1988
- Cystic fibrosis screening by dried blood spot trypsin assay: Results in 75,000 newborn infantsThe Journal of Pediatrics, 1983
- DRIED-BLOOD SPOT SCREENING FOR CYSTIC FIBROSIS IN THE NEWBORNThe Lancet, 1979